Literature DB >> 32773955

Lymphedema: Conventional to Cutting Edge Treatment.

Duane Wang1, Daniel Lyons1, Roman Skoracki1.   

Abstract

Lymphedema of the extremities related to oncologic therapies such as cancer surgery, radiation therapy, and chemotherapy is a major long-term cause of morbidity for cancer patients. Both nonsurgical and surgical management strategies have been developed. The goals of these therapies are to achieve volume reduction of the affected extremity, a reduction in patient symptoms, and a reduction in associated morbidities such as recurrent soft-tissue infections. In this article, we review both nonsurgical and surgical management strategies. Traditional surgical therapy has focused on more ablative techniques such as the Charles procedure and suction-assisted lipectomy/liposuction. However, newer more physiologic surgical methods such as lymphovenous anastomoses and vascularized lymph node transfers have become a more common treatment modality for the management of this complex problem. © Thieme Medical Publishers.

Entities:  

Keywords:  interventional radiology; lymphedema; lymphovenous bypass; vascularized lymph node transfer

Year:  2020        PMID: 32773955      PMCID: PMC7394577          DOI: 10.1055/s-0040-1713447

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  51 in total

1.  A comparison of the effectiveness of complex decongestive physiotherapy and stellate ganglion block with triamcinolone administration in breast cancer-related lymphedema patients.

Authors:  Jeong-Gil Kim; Soon Ook Bae; Kwan Sik Seo
Journal:  Support Care Cancer       Date:  2015-01-11       Impact factor: 3.603

Review 2.  Liposuction in Lymphedema Treatment.

Authors:  Håkan Brorson
Journal:  J Reconstr Microsurg       Date:  2015-04-20       Impact factor: 2.873

Review 3.  The surgical treatment of lymphedema: a systematic review of the contemporary literature (2004-2010).

Authors:  Janice N Cormier; Loren Rourke; Melissa Crosby; David Chang; Jane Armer
Journal:  Ann Surg Oncol       Date:  2011-08-24       Impact factor: 5.344

Review 4.  Lymphedema and microsurgery.

Authors:  C Campisi; F Boccardo
Journal:  Microsurgery       Date:  2002       Impact factor: 2.425

5.  A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle.

Authors:  Ming-Huei Cheng; Jung-Ju Huang; Ju-Jung Huang; Dung H Nguyen; Michel Saint-Cyr; Michael R Zenn; Bien Keem Tan; Chyi-Long Lee
Journal:  Gynecol Oncol       Date:  2012-04-17       Impact factor: 5.482

6.  Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.

Authors:  Ya-Chen Tina Shih; Ying Xu; Janice N Cormier; Sharon Giordano; Sheila H Ridner; Thomas A Buchholz; George H Perkins; Linda S Elting
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

7.  Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes.

Authors:  Ming-Huei Cheng; Shin-Cheh Chen; Steven L Henry; Bien Keem Tan; Miffy Chia-Yu Lin; Ju-Jung Huang
Journal:  Plast Reconstr Surg       Date:  2013-06       Impact factor: 4.730

8.  Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

Authors:  C L Loprinzi; J W Kugler; J A Sloan; T W Rooke; S K Quella; P Novotny; R B Mowat; J C Michalak; P J Stella; R Levitt; L K Tschetter; H Windschitl
Journal:  N Engl J Med       Date:  1999-02-04       Impact factor: 91.245

Review 9.  Vascularized Lymph Node Transfer for Lymphedema.

Authors:  Mark V Schaverien; Ido Badash; Ketan M Patel; Jesse C Selber; Ming-Huei Cheng
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

Review 10.  A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.

Authors:  Ramon Garza; Roman Skoracki; Karen Hock; Stephen P Povoski
Journal:  BMC Cancer       Date:  2017-07-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.